THAR
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Tharimmune receives positive FDA feedback for TH104 prophylaxis program against respiratory depression from fentanyl and ultrapowerful opioidsNov 13, 2025
- Tharimmune reports pharmacokinetic simulation results for TH104 as prophylaxis against respiratory depression from fentanyl and ultrapotent opioids, highlighting potential superiority over existing treatmentsAug 20, 2025
- Tharimmune secures key global patents for TH-104, laying foundation for broader indications following initial development as a national security medical countermeasure against weaponized fentanylAug 13, 2025
- Tharimmune presents positive clinical data on TH104 metabolic profile; advances opioid overdose prevention program after FDA feedbackMay 6, 2025